The biotech sciences include genetics, genetic engineering, gene therapy, applied immunology, and bioengineering. Companies that break ground in these areas may profit handsomely. Those that do ...

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas ... acceleration in the number of biotech companies seeking public listings after a two-year ...

China is teeming with promising science in areas such as oncology and immunology ... comes not only from other VC firms or even biotech companies. It’s coming from big pharma, he said.

This is not about doing it all but about translating external trends into actionable strategies that keep companies ... the future of biotech The convergence of oncology and immunology is not ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

About two-thirds of the companies that debuted ... central nervous system (CNS), immunology and inflammation (I&I) or oncology spaces, Surti estimates. Obesity biotech Aardvark eyes IPO as ...